首页 > 最新文献

Journal of minimally invasive gynecology最新文献

英文 中文
Novel Use of Ultrasound-Guided Radiofrequency Ablation for the Treatment of a Large Uterine Fibroid During Cesarean Delivery. 超声引导下射频消融治疗剖宫产中大子宫肌瘤的新应用。
IF 3.3 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-05 DOI: 10.1016/j.jmig.2025.12.040
Jamie Kroft, Noor Niyar N Ladhani, Patricia E Lee
{"title":"Novel Use of Ultrasound-Guided Radiofrequency Ablation for the Treatment of a Large Uterine Fibroid During Cesarean Delivery.","authors":"Jamie Kroft, Noor Niyar N Ladhani, Patricia E Lee","doi":"10.1016/j.jmig.2025.12.040","DOIUrl":"https://doi.org/10.1016/j.jmig.2025.12.040","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145917672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synergistic Effects of Endometriosis and Preeclampsia on Adverse Pregnancy Outcomes: A population database cohort study. 子宫内膜异位症和先兆子痫对不良妊娠结局的协同作用:一项人口数据库队列研究。
IF 3.3 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-04 DOI: 10.1016/j.jmig.2025.12.042
Paulina Garcia de Alba Graue, Eva Suarthana, Togas Tulandi

Study objective: Endometriosis affects approximately 10% of women of reproductive age and is associated with an increased risk of adverse pregnancy outcomes. However, the relationship between preeclampsia, endometriosis, and subsequent adverse pregnancy outcomes remains unclear. The purpose of our study was to evaluate the association between endometriosis and preeclampsia, and to assess their combined effect on preterm birth and cesarean delivery.

Design: Women with diagnoses of endometriosis and preeclampsia were identified using ICD-9 codes. A multivariable logistic regression model was used to estimate adjusted odds ratios (aORs) for maternal age, race, insurance status, smoking, obesity, chronic hypertension, anxiety, depression, gestational hypertension, and gestational diabetes. Additionally, we evaluated the combined effects of endometriosis and preeclampsia on preterm birth and cesarean delivery.

Setting: The Healthcare Cost and Utilization Project - Nationwide Inpatient Sample (HCUP-NIS) 2004 to 2014.

Patients: 9,082,246 pregnant women aged 15-49 years.

Interventions: None.

Measurements and main results: There were 652,354 (7.18%) patients who had preterm delivery and 2,936,759 (32.3%) had Cesarean delivery. Endometriosis was diagnosed in 5,634 (0.1%), preeclampsia in 326,195 (3.6%), and both conditions in 318 (0.003%) patients. Women with endometriosis alone had 56% higher odds of preeclampsia (aOR = 1.556, 95% CI: 1.414-1.712). When evaluating the association with preterm birth, endometriosis alone increased the odds (aOR = 1.556, 95% CI: 1.414-1.712), preeclampsia alone quadrupled the odds (aOR = 4.08, 95% CI: 4.04-4.12), and the combined presence of both conditions further elevated the risk (aOR = 5.76, 95% CI: 4.41-7.52). Regarding cesarean delivery, the odds were also heightened: endometriosis alone had an aOR of 6.13 (95% CI: 5.73-6.56), preeclampsia alone had an aOR of 2.45 (95% CI: 2.43-2.47), and the combined exposure resulted in an aOR of 12.55 (95% CI: 8.82-17.87).

Conclusion: Endometriosis is associated with preeclampsia, and when both conditions co-occur, the likelihood of preterm birth and cesarean delivery is markedly amplified.

研究目的:子宫内膜异位症影响约10%的育龄妇女,并与不良妊娠结局的风险增加有关。然而,子痫前期、子宫内膜异位症和随后的不良妊娠结局之间的关系尚不清楚。我们研究的目的是评估子宫内膜异位症和子痫前期的关系,并评估它们对早产和剖宫产的综合影响。设计:诊断为子宫内膜异位症和子痫前期的妇女使用ICD-9代码进行鉴定。采用多变量logistic回归模型估计产妇年龄、种族、保险状况、吸烟、肥胖、慢性高血压、焦虑、抑郁、妊娠期高血压和妊娠期糖尿病的校正优势比(aORs)。此外,我们评估了子宫内膜异位症和先兆子痫对早产和剖宫产的综合影响。背景:2004 - 2014年全国住院患者样本(HCUP-NIS)医疗成本与利用项目。患者:9082246名15-49岁的孕妇。干预措施:没有。测量结果及主要结果:早产患者652354例(7.18%),剖宫产患者2936759例(32.3%)。子宫内膜异位症患者为5634例(0.1%),先兆子痫患者为326195例(3.6%),两种情况均有318例(0.003%)。单独患有子宫内膜异位症的妇女发生子痫前期的几率高出56% (aOR = 1.556,95% CI: 1.414-1.712)。在评估子宫内膜异位症与早产的相关性时,单独子宫内膜异位症增加了早产的几率(aOR = 1.556,95% CI: 1.414-1.712),单独子痫前期增加了四倍的几率(aOR = 4.08,95% CI: 4.04-4.12),两种情况的合并进一步增加了早产的风险(aOR = 5.76,95% CI: 4.41-7.52)。剖宫产的风险也增加了:子宫内膜异位症单独的aOR为6.13 (95% CI: 5.73-6.56),子痫前期单独的aOR为2.45 (95% CI: 2.43-2.47),两者联合暴露导致aOR为12.55 (95% CI: 8.82-17.87)。结论:子宫内膜异位症与子痫前期有关,当这两种情况同时发生时,早产和剖宫产的可能性明显增加。
{"title":"Synergistic Effects of Endometriosis and Preeclampsia on Adverse Pregnancy Outcomes: A population database cohort study.","authors":"Paulina Garcia de Alba Graue, Eva Suarthana, Togas Tulandi","doi":"10.1016/j.jmig.2025.12.042","DOIUrl":"https://doi.org/10.1016/j.jmig.2025.12.042","url":null,"abstract":"<p><strong>Study objective: </strong>Endometriosis affects approximately 10% of women of reproductive age and is associated with an increased risk of adverse pregnancy outcomes. However, the relationship between preeclampsia, endometriosis, and subsequent adverse pregnancy outcomes remains unclear. The purpose of our study was to evaluate the association between endometriosis and preeclampsia, and to assess their combined effect on preterm birth and cesarean delivery.</p><p><strong>Design: </strong>Women with diagnoses of endometriosis and preeclampsia were identified using ICD-9 codes. A multivariable logistic regression model was used to estimate adjusted odds ratios (aORs) for maternal age, race, insurance status, smoking, obesity, chronic hypertension, anxiety, depression, gestational hypertension, and gestational diabetes. Additionally, we evaluated the combined effects of endometriosis and preeclampsia on preterm birth and cesarean delivery.</p><p><strong>Setting: </strong>The Healthcare Cost and Utilization Project - Nationwide Inpatient Sample (HCUP-NIS) 2004 to 2014.</p><p><strong>Patients: </strong>9,082,246 pregnant women aged 15-49 years.</p><p><strong>Interventions: </strong>None.</p><p><strong>Measurements and main results: </strong>There were 652,354 (7.18%) patients who had preterm delivery and 2,936,759 (32.3%) had Cesarean delivery. Endometriosis was diagnosed in 5,634 (0.1%), preeclampsia in 326,195 (3.6%), and both conditions in 318 (0.003%) patients. Women with endometriosis alone had 56% higher odds of preeclampsia (aOR = 1.556, 95% CI: 1.414-1.712). When evaluating the association with preterm birth, endometriosis alone increased the odds (aOR = 1.556, 95% CI: 1.414-1.712), preeclampsia alone quadrupled the odds (aOR = 4.08, 95% CI: 4.04-4.12), and the combined presence of both conditions further elevated the risk (aOR = 5.76, 95% CI: 4.41-7.52). Regarding cesarean delivery, the odds were also heightened: endometriosis alone had an aOR of 6.13 (95% CI: 5.73-6.56), preeclampsia alone had an aOR of 2.45 (95% CI: 2.43-2.47), and the combined exposure resulted in an aOR of 12.55 (95% CI: 8.82-17.87).</p><p><strong>Conclusion: </strong>Endometriosis is associated with preeclampsia, and when both conditions co-occur, the likelihood of preterm birth and cesarean delivery is markedly amplified.</p>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Duplicated Ureter: Double the Vigilance. 重复输尿管:加倍警惕。
IF 3.3 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-03 DOI: 10.1016/j.jmig.2025.12.031
Ahmad Hasan, Dilkash Kajal, Nigel Pereira
{"title":"Duplicated Ureter: Double the Vigilance.","authors":"Ahmad Hasan, Dilkash Kajal, Nigel Pereira","doi":"10.1016/j.jmig.2025.12.031","DOIUrl":"https://doi.org/10.1016/j.jmig.2025.12.031","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145906091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AI-Enhanced MRI Radiomics for Discriminating Active and Fibrotic Lesions to Support Therapeutic Decision-Making in Deep Endometriosis. 人工智能增强的MRI放射组学用于区分活性和纤维化病变,以支持深部子宫内膜异位症的治疗决策。
IF 3.3 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-03 DOI: 10.1016/j.jmig.2025.12.037
Sara Peluso, Vincenzo Lucidi, Maria Chiara Di Giovanni, Linda Bertoldo, Valeria De Gobbi, Alberto Aguzzi, Nico Curti, Riccardo Biondi, Antonio Raffone, Renato Seracchioli, Gastone Castellani, Cristina Mosconi, Diego Raimondo

Objective: This study investigates whether quantitative analysis of preoperative Magnetic Resonance Imaging (MRI) scans can differentiate deep infiltrating endometriosis (DIE) lesion types (active or fibrotic) and associate them with reported pain symptoms.

Design: monocenter, observational, retrospective accuracy study SETTING: Academic Hospital IRCCS Policlinico di S. Orsola Bologna, Italy PARTICIPANTS: All patients with histologically confirmed DIE who had undergone pre-operative MRI were considered for recruitment during the study period (12/2022-12/2023).

Interventions: Histological assessment was performed on all surgical specimens categorizing the lesions in active lesions (AL) and fibrotic lesions (FL). All patients underwent pelvic MRI prior to surgery, and DICOM files were retrieved. Radiomic features were extracted using PyRadiomics (v3.1.0). In addition to radiomic data, morphological features were extracted. A genetic algorithm (GA) was used for features selection to identify relevant features and build classification models. Machine learning (ML) pipelines, tuned using leave-one-out cross-validation and evaluated via balanced accuracy, Matthews Correlation Coefficient, sensitivity and specificity, were developed to identify the most informative morphological and textural features for lesion classification and pain severity classification.

Results: Sixty-one women were enrolled. The integration of radiomic and graphomic enabled the extraction of insightful imaging features statistically linked to histological lesion types and pain symptomatology. The ML models proved promising classification performance under the leave-one-out cross-validation framework, identifying imaging biomarkers that differentiate fibrotic lesions from active stromal ones (balanced accuracy: 72.7%) and correlate with pain profiles (reaching a maximum of 88.0% of balanced accuracy for chronic pelvic pain). These results highlight the potential of imaging-based phenotyping in DIE.

Conclusions: The results support the feasibility of a non-invasive, image-based approach to preoperatively characterize DIE lesions. By combining radiomic, graphomic, and ML, our results showed that a rich characterization of active or fibrotic DIE lesions could enable their differentiation and their association with pain symptoms.

目的:本研究探讨术前磁共振成像(MRI)扫描的定量分析是否可以区分深部浸润性子宫内膜异位症(DIE)病变类型(活动性或纤维化性),并将其与报告的疼痛症状联系起来。设计:单中心、观察性、回顾性准确性研究设置:意大利博洛尼亚学术医院IRCCS Policlinico di S. Orsola Bologna参与者:所有经组织学证实且术前MRI检查的死亡患者均被纳入研究期间(2022年12月至2023年12月)。干预措施:对所有手术标本进行组织学评估,将病变分为活动性病变(AL)和纤维化病变(FL)。所有患者在手术前均行盆腔MRI检查,并检索DICOM档案。使用PyRadiomics (v3.1.0)提取放射组学特征。除了放射组学数据外,还提取了形态学特征。采用遗传算法进行特征选择,识别相关特征并建立分类模型。机器学习(ML)管道使用留一交叉验证进行调整,并通过平衡准确性、马修斯相关系数、敏感性和特异性进行评估,以确定最具信息的形态和纹理特征,用于病变分类和疼痛严重程度分类。结果:61名女性入组。放射组学和图形组学的整合使有洞察力的影像特征的提取与组织学病变类型和疼痛症状统计相关。ML模型在留一交叉验证框架下证明了有希望的分类性能,识别出区分纤维化病变和活动间质病变的成像生物标志物(平衡精度:72.7%),并与疼痛谱相关(慢性盆腔疼痛的平衡精度最高达到88.0%)。这些结果突出了基于成像的表型在DIE中的潜力。结论:该结果支持无创、基于图像的方法对DIE病变进行术前表征的可行性。通过结合放射组学、图组学和ML,我们的研究结果表明,活动性或纤维化性DIE病变的丰富特征可以使其分化并与疼痛症状相关联。
{"title":"AI-Enhanced MRI Radiomics for Discriminating Active and Fibrotic Lesions to Support Therapeutic Decision-Making in Deep Endometriosis.","authors":"Sara Peluso, Vincenzo Lucidi, Maria Chiara Di Giovanni, Linda Bertoldo, Valeria De Gobbi, Alberto Aguzzi, Nico Curti, Riccardo Biondi, Antonio Raffone, Renato Seracchioli, Gastone Castellani, Cristina Mosconi, Diego Raimondo","doi":"10.1016/j.jmig.2025.12.037","DOIUrl":"https://doi.org/10.1016/j.jmig.2025.12.037","url":null,"abstract":"<p><strong>Objective: </strong>This study investigates whether quantitative analysis of preoperative Magnetic Resonance Imaging (MRI) scans can differentiate deep infiltrating endometriosis (DIE) lesion types (active or fibrotic) and associate them with reported pain symptoms.</p><p><strong>Design: </strong>monocenter, observational, retrospective accuracy study SETTING: Academic Hospital IRCCS Policlinico di S. Orsola Bologna, Italy PARTICIPANTS: All patients with histologically confirmed DIE who had undergone pre-operative MRI were considered for recruitment during the study period (12/2022-12/2023).</p><p><strong>Interventions: </strong>Histological assessment was performed on all surgical specimens categorizing the lesions in active lesions (AL) and fibrotic lesions (FL). All patients underwent pelvic MRI prior to surgery, and DICOM files were retrieved. Radiomic features were extracted using PyRadiomics (v3.1.0). In addition to radiomic data, morphological features were extracted. A genetic algorithm (GA) was used for features selection to identify relevant features and build classification models. Machine learning (ML) pipelines, tuned using leave-one-out cross-validation and evaluated via balanced accuracy, Matthews Correlation Coefficient, sensitivity and specificity, were developed to identify the most informative morphological and textural features for lesion classification and pain severity classification.</p><p><strong>Results: </strong>Sixty-one women were enrolled. The integration of radiomic and graphomic enabled the extraction of insightful imaging features statistically linked to histological lesion types and pain symptomatology. The ML models proved promising classification performance under the leave-one-out cross-validation framework, identifying imaging biomarkers that differentiate fibrotic lesions from active stromal ones (balanced accuracy: 72.7%) and correlate with pain profiles (reaching a maximum of 88.0% of balanced accuracy for chronic pelvic pain). These results highlight the potential of imaging-based phenotyping in DIE.</p><p><strong>Conclusions: </strong>The results support the feasibility of a non-invasive, image-based approach to preoperatively characterize DIE lesions. By combining radiomic, graphomic, and ML, our results showed that a rich characterization of active or fibrotic DIE lesions could enable their differentiation and their association with pain symptoms.</p>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145906172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regarding "Live birth outcomes in patients with recurrent pregnancy loss and Asherman syndrome: A retrospective cohort study". 关于“复发性妊娠丢失和Asherman综合征患者的活产结局:一项回顾性队列研究”。
IF 3.3 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-03 DOI: 10.1016/j.jmig.2025.12.036
Xinyou Yu, Fang Liu, XiaoYan Wang, MeiJuan Li, LanHua Yang, Lihua Pan
{"title":"Regarding \"Live birth outcomes in patients with recurrent pregnancy loss and Asherman syndrome: A retrospective cohort study\".","authors":"Xinyou Yu, Fang Liu, XiaoYan Wang, MeiJuan Li, LanHua Yang, Lihua Pan","doi":"10.1016/j.jmig.2025.12.036","DOIUrl":"https://doi.org/10.1016/j.jmig.2025.12.036","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145906226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of Tubal Patency on Endometriosis Recurrence: a Retrospective Matched Case-control Study. 输卵管通畅对子宫内膜异位症复发的影响:一项回顾性匹配病例对照研究。
IF 3.3 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-03 DOI: 10.1016/j.jmig.2025.12.041
Sofie Neutens, Arne Vanhie, Barbara Van Elst, Annouschka Laenen, Christel Meuleman, Carla Tomassetti

Study objective: To study if bilateral non-patency of fallopian tubes is correlated with a lower recurrence rate of endometriosis.

Design: Retrospective 2:1 matched case control study.

Setting: University hospital with tertiary referral center for fertility and endometriosis surgery in Leuven, Belgium.

Patients: All patients undergoing complete laparoscopic excision of any rASRM-stage endometriosis between 2010 and 2014 (n=896).

Intervention: Comparison between patients with bilateral non-patent or absent fallopian tubes versus matched controls with at least one patent fallopian tube.

Measurements and main results: Primary outcome was the recurrence rate which was analyzed on 4 levels: overall recurrence, symptom recurrence, recurrence on imaging and need for reintervention. Out of 896 patients, 49 had bilateral non-patent or absent fallopian tubes. These cases were compared with 98 matched controls with at least one patent fallopian tube. Symptoms recurred in 12.2% of the cases (n=6) and 25.5% of the controls (n =25) (P=0.09). Recurrence was confirmed by imaging in 8% of the cases (n=4) and in 10.2% of the controls (n=10) (P=0.77). In 3 patients of the case group and in 12 patients of the control group, there was a need for reintervention (P=0.39). Within this subgroup, recurrence of endometriosis was histologically confirmed in none of the patients of the case group and in 5 patients of the control group (P=0.51).

Conclusion: This study did not observe a statistically significant reduction in endometriosis recurrence in patients with bilateral occlusion/absence of the fallopian tubes after endometriosis surgery. A type II error may count for this result.

研究目的:探讨双侧输卵管不通畅与子宫内膜异位症复发率的相关性。设计:回顾性2:1匹配病例对照研究。地点:比利时鲁汶大学医院生育和子宫内膜异位症三级转诊中心。患者:所有在2010年至2014年间接受腹腔镜完全切除任何rasrm期子宫内膜异位症的患者(n=896)。干预:双侧输卵管未闭或缺失患者与至少有一条输卵管未闭的匹配对照组的比较。测量方法及主要结果:主要观察指标为复发率,从总体复发率、症状复发率、影像学复发率、再干预率4个水平进行分析。896例患者中,49例双侧输卵管未通畅或缺失。这些病例与98例至少有一条输卵管未闭的对照组进行比较。12.2%的病例(n=6)和25.5%的对照组(n= 25)出现症状复发(P=0.09)。8%的病例(n=4)和10.2%的对照组(n=10)经影像学证实复发(P=0.77)。病例组3例,对照组12例,需要再干预(P=0.39)。在该亚组中,病例组中没有一例患者组织学上证实子宫内膜异位症复发,对照组中有5例患者(P=0.51)。结论:本研究未观察到双侧输卵管闭塞/缺失患者在子宫内膜异位症手术后复发的统计学显著降低。type II错误可能会计算在此结果中。
{"title":"Influence of Tubal Patency on Endometriosis Recurrence: a Retrospective Matched Case-control Study.","authors":"Sofie Neutens, Arne Vanhie, Barbara Van Elst, Annouschka Laenen, Christel Meuleman, Carla Tomassetti","doi":"10.1016/j.jmig.2025.12.041","DOIUrl":"https://doi.org/10.1016/j.jmig.2025.12.041","url":null,"abstract":"<p><strong>Study objective: </strong>To study if bilateral non-patency of fallopian tubes is correlated with a lower recurrence rate of endometriosis.</p><p><strong>Design: </strong>Retrospective 2:1 matched case control study.</p><p><strong>Setting: </strong>University hospital with tertiary referral center for fertility and endometriosis surgery in Leuven, Belgium.</p><p><strong>Patients: </strong>All patients undergoing complete laparoscopic excision of any rASRM-stage endometriosis between 2010 and 2014 (n=896).</p><p><strong>Intervention: </strong>Comparison between patients with bilateral non-patent or absent fallopian tubes versus matched controls with at least one patent fallopian tube.</p><p><strong>Measurements and main results: </strong>Primary outcome was the recurrence rate which was analyzed on 4 levels: overall recurrence, symptom recurrence, recurrence on imaging and need for reintervention. Out of 896 patients, 49 had bilateral non-patent or absent fallopian tubes. These cases were compared with 98 matched controls with at least one patent fallopian tube. Symptoms recurred in 12.2% of the cases (n=6) and 25.5% of the controls (n =25) (P=0.09). Recurrence was confirmed by imaging in 8% of the cases (n=4) and in 10.2% of the controls (n=10) (P=0.77). In 3 patients of the case group and in 12 patients of the control group, there was a need for reintervention (P=0.39). Within this subgroup, recurrence of endometriosis was histologically confirmed in none of the patients of the case group and in 5 patients of the control group (P=0.51).</p><p><strong>Conclusion: </strong>This study did not observe a statistically significant reduction in endometriosis recurrence in patients with bilateral occlusion/absence of the fallopian tubes after endometriosis surgery. A type II error may count for this result.</p>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145906099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of intramural perforated levonorgestrel-intrauterine system with mesosalpinx entrapment. 左炔诺孕酮-宫内系统穿孔伴输卵管系膜夹持1例。
IF 3.3 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-03 DOI: 10.1016/j.jmig.2025.12.032
Yui Honjo, Junko Ishigaki, Kenichi Someya, Bao-Liang Lin
{"title":"A case of intramural perforated levonorgestrel-intrauterine system with mesosalpinx entrapment.","authors":"Yui Honjo, Junko Ishigaki, Kenichi Someya, Bao-Liang Lin","doi":"10.1016/j.jmig.2025.12.032","DOIUrl":"https://doi.org/10.1016/j.jmig.2025.12.032","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145906085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author's Reply. 作者的回答。
IF 3.3 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-03 DOI: 10.1016/j.jmig.2025.12.039
Bahi Fayek, Yang Doris Liu, Mohamed A Bedaiwy
{"title":"Author's Reply.","authors":"Bahi Fayek, Yang Doris Liu, Mohamed A Bedaiwy","doi":"10.1016/j.jmig.2025.12.039","DOIUrl":"https://doi.org/10.1016/j.jmig.2025.12.039","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145906096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Female Sexual Desire, Arousal, and Orgasmic Dysfunctions: A Systematic Review and Meta-Analysis of Treatment Options 题目:女性性欲、性唤起和性高潮功能障碍:治疗方案的系统回顾和荟萃分析。
IF 3.3 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.jmig.2025.06.004
Rafaela Germano Toledo MD , William D. Winkelman MD , Daniela Reyes-Gonzalez MD , Sophie Bergeron PhD , Anne Fladger MLS , Michele R. Hacker ScD , Mallika Anand MD, MS

Objective

To conduct a systematic review and meta-analysis of treatments for female sexual desire, arousal, and orgasmic dysfunction in patients without sexual pain conditions.

Data Source

MEDLINE, Embase, Web of Science, Cochrane Library, PsycINFO, and ClinicalTrials.gov.

Methods of Study Selection

Following the initial search in December 2024, a total of 8994 abstracts were screened, 278 full-text articles were reviewed, and 36 studies met criteria for data abstraction including a patient population with female sexual dysfunction (FSD) of desire, arousal, and/or orgasm (DAO) and outcome measures including the Female Sexual Function Index (FSFI), its DAO subscales, and the Female Sexual Distress Scale (FSDS). Studies including patients with sexual pain conditions were excluded. Two reviewers independently conducted each phase.

Tabulation, Integration, and Results

Of the 36 studies, 26 were RCTs and 10 were single-arm trials. Ten studies evaluated cognitive behavioral therapy (CBT), 24 investigated medication therapy, and 2 investigated devices. Meta-analyses were conducted for mindfulness-based CBT, flibanserin, and bremelanotide. Mindfulness-based CBT significantly improved total FSFI and subscales of desire, arousal, and orgasm. Conversely, flibanserin improved total FSFI and desire while bremelanotide improved total FSFI and its desire and arousal subscales. No studies directly compared CBT to pharmacotherapy.

Conclusion

In this systematic review of treatments of females with sexual DAO dysfunctions without pain, we found that CBT improves DAO; flibanserin improves desire; and bremelanotide improves both desire and arousal; and all 3 treatments reduce distress. Our findings align with previous literature and expand upon it to include multiple treatment modalities. This broader perspective offers a starting point for clinicians, including gynecologists, who frequently serve as the first point of care for FSD. Conclusions regarding most other treatments could not be drawn due to limited numbers of studies of FSD excluding pain, heterogeneous terminology for DAO disorders, and varying outcome measures across studies.
目的:对无性疼痛患者的女性性欲、性唤起和性高潮功能障碍的治疗方法进行系统回顾和荟萃分析。数据来源:MEDLINE, Embase, Web of Science, Cochrane Library, PsycINFO, clinicaltrials .gov。在2024年12月的首次检索之后,共有8,994篇摘要被筛选,278篇全文文章被审查,36项研究符合数据提取标准,包括女性性欲、觉醒和/或性高潮(DAO)的性功能障碍(FSD)患者群体,以及包括女性性功能指数(FSFI)、其DAO子量表和女性性困扰量表(FSDS)在内的结果测量。包括性疼痛患者的研究被排除在外。每个阶段由两名评审人员独立进行。制表、整合和结果:36项研究中,26项为随机对照试验,10项为单臂试验。10项研究评估认知行为疗法(CBT), 24项研究调查药物治疗,2项研究调查设备。对以正念为基础的CBT、氟立班色林和布雷美诺肽进行meta分析。以正念为基础的CBT显著改善了FSFI总分和欲望、觉醒和性高潮的分量表。相反,氟班色林改善了总FSFI和欲望,而布雷美诺肽改善了总FSFI及其欲望和觉醒亚量表。没有研究直接比较CBT和药物治疗。结论:本研究对无疼痛性DAO功能障碍女性的治疗进行了系统回顾,我们发现CBT改善了DAO;氟立班色林改善性欲;布雷梅酸酯能提高欲望和觉醒;这三种治疗方法都能减轻痛苦。我们的研究结果与以前的文献一致,并将其扩展到包括多种治疗方式。这种更广阔的视角为临床医生提供了一个起点,包括妇科医生,他们经常作为女性性功能障碍的第一护理点。由于FSD的研究数量有限,不包括疼痛,DAO障碍的术语不同,研究结果不同,因此无法得出关于大多数其他治疗方法的结论。
{"title":"Female Sexual Desire, Arousal, and Orgasmic Dysfunctions: A Systematic Review and Meta-Analysis of Treatment Options","authors":"Rafaela Germano Toledo MD ,&nbsp;William D. Winkelman MD ,&nbsp;Daniela Reyes-Gonzalez MD ,&nbsp;Sophie Bergeron PhD ,&nbsp;Anne Fladger MLS ,&nbsp;Michele R. Hacker ScD ,&nbsp;Mallika Anand MD, MS","doi":"10.1016/j.jmig.2025.06.004","DOIUrl":"10.1016/j.jmig.2025.06.004","url":null,"abstract":"<div><h3>Objective</h3><div>To conduct a systematic review and meta-analysis of treatments for female sexual desire, arousal, and orgasmic dysfunction in patients without sexual pain conditions.</div></div><div><h3>Data Source</h3><div>MEDLINE, Embase, Web of Science, Cochrane Library, PsycINFO, and ClinicalTrials.gov.</div></div><div><h3>Methods of Study Selection</h3><div>Following the initial search in December 2024, a total of 8994 abstracts were screened, 278 full-text articles were reviewed, and 36 studies met criteria for data abstraction including a patient population with female sexual dysfunction (FSD) of desire, arousal, and/or orgasm (DAO) and outcome measures including the Female Sexual Function Index (FSFI), its DAO subscales, and the Female Sexual Distress Scale (FSDS). Studies including patients with sexual pain conditions were excluded. Two reviewers independently conducted each phase.</div></div><div><h3>Tabulation, Integration, and Results</h3><div>Of the 36 studies, 26 were RCTs and 10 were single-arm trials. Ten studies evaluated cognitive behavioral therapy (CBT), 24 investigated medication therapy, and 2 investigated devices. Meta-analyses were conducted for mindfulness-based CBT, flibanserin, and bremelanotide. Mindfulness-based CBT significantly improved total FSFI and subscales of desire, arousal, and orgasm. Conversely, flibanserin improved total FSFI and desire while bremelanotide improved total FSFI and its desire and arousal subscales. No studies directly compared CBT to pharmacotherapy.</div></div><div><h3>Conclusion</h3><div>In this systematic review of treatments of females with sexual DAO dysfunctions without pain, we found that CBT improves DAO; flibanserin improves desire; and bremelanotide improves both desire and arousal; and all 3 treatments reduce distress. Our findings align with previous literature and expand upon it to include multiple treatment modalities. This broader perspective offers a starting point for clinicians, including gynecologists, who frequently serve as the first point of care for FSD. Conclusions regarding most other treatments could not be drawn due to limited numbers of studies of FSD excluding pain, heterogeneous terminology for DAO disorders, and varying outcome measures across studies.</div></div>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":"33 1","pages":"Pages 16-33.e3"},"PeriodicalIF":3.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144340208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sexual Devices and Erotica 性装置和情色作品
IF 3.3 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.jmig.2025.09.001
Sophie Tucker BA , Eliza Burr MD , Sara Perelmuter MPhil , Quynh Tran BS , Alexis Thompson MPH , Julia Rubin BS , Melissa Davide BA , Ibukunoluwa Omole BA , Yash Adroja BA , Jessica Yih MD , Rachel Rubin MD , Christine Vaccaro DO

Introduction

Sexual wellness is directly associated with overall physical and mental health. Sex span, which is the period spent enjoying a satisfying, vibrant, and joyful sexual life, is directly correlated to quality of life. Gynecologic surgeons are well-positioned to discuss sexual function with their patients as it pertains to a variety of pathologic pelvic conditions, including pelvic pain disorders, urinary/bowel incontinence, pelvic organ prolapse, as well as urogenital and non-urogenital cancers and other related conditions.

Objective

Describe sexual devices, tools, and erotica commonly used by female patients, and provide resources for clinicians. Vibrators, dildos, depth-limiting devices/collision aids, dilators, wands, and erotica are discussed in the context of evidence-based practices when available.

Conclusion

Sexual devices, tools, and erotica are means for both enhancing sexual pleasure and augmenting treatment of female sexual dysfunction. Despite a lack of standardized medical educational resources devoted to female sexuality, clinician familiarity with sexual devices, tools, practices, and erotica is necessary to build a comprehensive treatment plan supporting sexual health-related quality of life.
性健康与整体身心健康直接相关。性生活的持续时间是指享受满意、充满活力和快乐的性生活的时间,它与生活质量直接相关。妇科外科医生可以很好地与患者讨论性功能,因为性功能涉及到各种盆腔病理性疾病,包括盆腔疼痛疾病、尿/肠失禁、盆腔器官脱垂、泌尿生殖器和非泌尿生殖器癌症以及其他相关疾病。目的了解女性患者常用的性器具、性工具和性用品,为临床医生提供参考。振动器,假阳具,深度限制装置/碰撞辅助,扩张器,棒,和情色的背景下讨论的证据实践时,可用。结论性器具、性工具和性用品是增强性快感和增强女性性功能障碍治疗的手段。尽管缺乏专门针对女性性行为的标准化医学教育资源,但临床医生对性设备、工具、实践和色情的熟悉对于建立支持与性健康相关的生活质量的综合治疗计划是必要的。
{"title":"Sexual Devices and Erotica","authors":"Sophie Tucker BA ,&nbsp;Eliza Burr MD ,&nbsp;Sara Perelmuter MPhil ,&nbsp;Quynh Tran BS ,&nbsp;Alexis Thompson MPH ,&nbsp;Julia Rubin BS ,&nbsp;Melissa Davide BA ,&nbsp;Ibukunoluwa Omole BA ,&nbsp;Yash Adroja BA ,&nbsp;Jessica Yih MD ,&nbsp;Rachel Rubin MD ,&nbsp;Christine Vaccaro DO","doi":"10.1016/j.jmig.2025.09.001","DOIUrl":"10.1016/j.jmig.2025.09.001","url":null,"abstract":"<div><h3>Introduction</h3><div>Sexual wellness is directly associated with overall physical and mental health. Sex span, which is the period spent enjoying a satisfying, vibrant, and joyful sexual life, is directly correlated to quality of life. Gynecologic surgeons are well-positioned to discuss sexual function with their patients as it pertains to a variety of pathologic pelvic conditions, including pelvic pain disorders, urinary/bowel incontinence, pelvic organ prolapse, as well as urogenital and non-urogenital cancers and other related conditions.</div></div><div><h3>Objective</h3><div>Describe sexual devices, tools, and erotica commonly used by female patients, and provide resources for clinicians. Vibrators, dildos, depth-limiting devices/collision aids, dilators, wands, and erotica are discussed in the context of evidence-based practices when available.</div></div><div><h3>Conclusion</h3><div>Sexual devices, tools, and erotica are means for both enhancing sexual pleasure and augmenting treatment of female sexual dysfunction. Despite a lack of standardized medical educational resources devoted to female sexuality, clinician familiarity with sexual devices, tools, practices, and erotica is necessary to build a comprehensive treatment plan supporting sexual health-related quality of life.</div></div>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":"33 1","pages":"Pages 100-109"},"PeriodicalIF":3.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145950173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of minimally invasive gynecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1